Non-Small Cell Carcinoma — Trials

Non-Small Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

6,756 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,752
Recruiting: 926
Ph III recruiting: 138
Growth YoY: +3.1%
Industry share: 44%
Top sponsor: AstraZeneca
Termination share: 38.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,045)

clinicaltrialsPublishedShowing 6,751–6,756 of 6,756 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00238849	Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.	unknown	Phase 2	40	Integrated Community Oncology NetworkOTHER	1	Oct 14, 2005	clinicaltrials
NCT00211952	Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients	suspended	Phase 3	542	Medical University of GdanskOTHER	1	Sep 21, 2005	clinicaltrials